Skip to main content

Seizures clinical trials at UC Davis
1 research study open to eligible people

  • A Study of the Safety and Effectiveness of Experimental Perampanel For Partial Onset Seizures

    open to eligible people ages 12 years and up

    This study will assess the retention rate of perampanel when given as monotherapy or first adjunctive therapy in participants with partial-onset seizures or primary generalized tonic clonic seizures. The study consists of 4 periods: a Screening Period (to start no earlier than 6 weeks before the first dose of study drug), a Titration Period (13 weeks), a Maintenance Period (39 weeks), and a Follow-Up Period (4 weeks).

    Sacramento, California and other locations

Last updated: